- Home
- SRZN vs IXHL Comparison
SRZN vs IXHL Comparison
Compare SRZN & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- IXHL
- Stock Information
- Founded
- SRZN 2015
- IXHL 2001
- Country
- SRZN United States
- IXHL Australia
- Employees
- SRZN N/A
- IXHL N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- IXHL
- Sector
- SRZN Health Care
- IXHL
- Exchange
- SRZN Nasdaq
- IXHL Nasdaq
- Market Cap
- SRZN 38.1M
- IXHL 39.2M
- IPO Year
- SRZN N/A
- IXHL N/A
- Fundamental
- Price
- SRZN $8.90
- IXHL $2.01
- Analyst Decision
- SRZN
- IXHL
- Analyst Count
- SRZN 0
- IXHL 0
- Target Price
- SRZN N/A
- IXHL N/A
- AVG Volume (30 Days)
- SRZN 33.9K
- IXHL 43.4K
- Earning Date
- SRZN 11-06-2024
- IXHL 11-14-2024
- Dividend Yield
- SRZN N/A
- IXHL N/A
- EPS Growth
- SRZN N/A
- IXHL N/A
- EPS
- SRZN N/A
- IXHL N/A
- Revenue
- SRZN $10,000,000.00
- IXHL $86,000.00
- Revenue This Year
- SRZN N/A
- IXHL N/A
- Revenue Next Year
- SRZN N/A
- IXHL N/A
- P/E Ratio
- SRZN N/A
- IXHL N/A
- Revenue Growth
- SRZN N/A
- IXHL N/A
- 52 Week Low
- SRZN $6.00
- IXHL $0.95
- 52 Week High
- SRZN $16.19
- IXHL $12.68
- Technical
- Relative Strength Index (RSI)
- SRZN 45.92
- IXHL 41.72
- Support Level
- SRZN $8.10
- IXHL $2.00
- Resistance Level
- SRZN $10.76
- IXHL $2.20
- Average True Range (ATR)
- SRZN 1.25
- IXHL 0.25
- MACD
- SRZN -0.16
- IXHL -0.09
- Stochastic Oscillator
- SRZN 22.90
- IXHL 0.00
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.